{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:18:53Z","timestamp":1781104733642,"version":"3.54.1"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010623","name":"Panepist\u1e17mio Thessal\u00edas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010623","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018996","name":"Hellenic Academic Libraries Link","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.vaccine.2026.128776","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T11:43:42Z","timestamp":1780141422000},"page":"128776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Lipid peroxidation marker malondialdehyde is an independent determinant of hepatitis B vaccine response in hemodialysis patients"],"prefix":"10.1016","volume":"87","author":[{"given":"Maria","family":"Divani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Katsanaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Poulianiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Lykotsetas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andriani","family":"Balatsouka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiota","family":"Makri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Tziastoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Stefanidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Eleftheriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128776_bb0005","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1111\/j.1523-1755.2000.00337.x","article-title":"Mortality caused by sepsis in patients with end-stage renal disease compared with the general population","volume":"58","author":"Sarnak","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.vaccine.2026.128776_bb0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ajic.2003.05.007","article-title":"Incidence of bloodstream infection in multicenter inception cohorts of hemodialysis patients","volume":"32","author":"Taylor","year":"2004","journal-title":"Am. J. Infect. Control"},{"key":"10.1016\/j.vaccine.2026.128776_bb0015","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1378\/chest.120.6.1883","article-title":"Pulmonary infectious mortality among patients with end-stage renal disease","volume":"120","author":"Sarnak","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.vaccine.2026.128776_bb0020","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijid.2022.05.046","article-title":"Tuberculosis incidence in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"122","author":"Alemu","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2026.128776_bb0025","first-page":"120","article-title":"Infections in hemodialysis: a concise review. Part II: blood transmitted viral infections","volume":"15","author":"Eleftheriadis","year":"2011","journal-title":"Hippokratia"},{"key":"10.1016\/j.vaccine.2026.128776_bb0030","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1525-139X.2007.00283.x","article-title":"Basic science and dialysis: disturbances of acquired immunity in hemodialysis patients","volume":"20","author":"Eleftheriadis","year":"2007","journal-title":"Semin. Dial."},{"key":"10.1016\/j.vaccine.2026.128776_bb0035","article-title":"Immune dysfunction in Uremia","volume":"12","author":"Cohen","year":"2020","journal-title":"Toxins (Basel) 2020"},{"key":"10.1016\/j.vaccine.2026.128776_bb0040","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.3390\/jcm11133759","article-title":"Immune system dysfunction and inflammation in hemodialysis patients: two sides of the same coin","volume":"11","author":"Campo","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.vaccine.2026.128776_bb0045","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1681\/ASN.0000000896","article-title":"Kidney disease as a driver of immunosenescence","volume":"37","author":"Song","year":"2026","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.vaccine.2026.128776_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2023.100775","article-title":"Vaccination for Patients Receiving Dialysis","volume":"6","author":"Sam","year":"2024","journal-title":"Kidney Medicine"},{"key":"10.1016\/j.vaccine.2026.128776_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2023.106080","article-title":"Global epidemiology of HBV infection among hemodialysis patients: A systematic review and meta-analysis","volume":"179","author":"Khalesi","year":"2023","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.vaccine.2026.128776_bb0060","doi-asserted-by":"crossref","first-page":"12018","DOI":"10.3748\/wjg.v20.i34.12018","article-title":"Factors affecting effectiveness of vaccination against hepatitis B virus in hemodialysis patients","volume":"20","author":"Eleftheriadis","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.vaccine.2026.128776_bb0065","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2025.2541873","article-title":"Optimizing hepatitis B vaccination in chronic kidney disease: a comprehensive scoping review of strategies across CKD stages, dialysis, and transplant populations","volume":"47","author":"Chancharoenthana","year":"2025","journal-title":"Ren. Fail."},{"key":"10.1016\/j.vaccine.2026.128776_bb0070","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/j.vaccine.2011.01.051","article-title":"Indoleamine 2,3-dioxygenase is increased in hemodialysis patients and affects immune response to hepatitis B vaccination","volume":"29","author":"Eleftheriadis","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128776_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-019-1529-1","article-title":"Clinical practice guideline management of blood borne viruses within the haemodialysis unit","volume":"20","author":"Garthwaite","year":"2019","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.vaccine.2026.128776_bb0080","doi-asserted-by":"crossref","DOI":"10.1177\/2054358117735563","article-title":"Association of neutrophil-to-lymphocyte ratio with inflammation and erythropoietin resistance in chronic dialysis patients","volume":"4","author":"Pineault","year":"2017","journal-title":"Can J Kidney Health Dis"},{"key":"10.1016\/j.vaccine.2026.128776_bb0085","article-title":"Intersecting pathways of inflammation, oxidative stress, and atherogenesis in the evaluation of CKD: emerging biomarkers PCSK9, EPHX2, AOPPs, and TBARSs","volume":"15","author":"Assani","year":"2025","journal-title":"Life (Basel)"},{"key":"10.1016\/j.vaccine.2026.128776_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262110670","article-title":"Assessment of AOPP, TBARS, and Inflammatory Status in Diabetic Nephropathy and Hemodialyzed Patients","volume":"26","author":"Caragea","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.vaccine.2026.128776_bb0095","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.3390\/ijms26136476","article-title":"Calprotectin as a biomarker for infectious diseases: a comparative review with conventional inflammatory markers","volume":"26","author":"Sejersen","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.vaccine.2026.128776_bb0100","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00011-009-0103-x","article-title":"Plasma calprotectin in chronically dialyzed end-stage renal disease patients","volume":"59","author":"Mal\u00ed\u010dkov\u00e1","year":"2009","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.vaccine.2026.128776_bb0105","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-020-01812-x","article-title":"The predictive role of serum calprotectin on mortality in hemodialysis patients with high phosphoremia","volume":"21","author":"Kanki","year":"2020","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.vaccine.2026.128776_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/lymphatics3010001","article-title":"Soluble IL-2R as a marker of T cell activation in immune-mediated diseases: review and case-based interpretation","volume":"3","author":"Oportus","year":"2025","journal-title":"Lymphatics"},{"key":"10.1016\/j.vaccine.2026.128776_bb0115","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/0886022X.2020.1761388","article-title":"The significance of serum levels of soluble interleukin-2 receptor in patients undergoing maintenance hemodialysis","volume":"42","author":"Chen","year":"2020","journal-title":"Ren. Fail."},{"key":"10.1016\/j.vaccine.2026.128776_bb0120","doi-asserted-by":"crossref","first-page":"882","DOI":"10.4049\/jimmunol.154.2.882","article-title":"Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes","volume":"154","author":"Descamps-Latscha","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2026.128776_bb0125","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.imlet.2011.08.004","article-title":"Soluble IgE receptors\u2014elements of the IgE network","volume":"141","author":"Platzer","year":"2011","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.vaccine.2026.128776_bb0130","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/ki.1993.123","article-title":"Soluble CD23 as an effector of immune dysregulation in chronic uremia and dialysis","volume":"43","author":"Descamps-Latscha","year":"1993","journal-title":"Kidney Int."},{"key":"10.1016\/j.vaccine.2026.128776_bb0135","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.vaccine.2021.03.074","article-title":"Long-term persistent immunogenicity after successful standard and triple-dosed hepatitis B vaccine in hemodialysis patients: A 3-year follow-up study in China","volume":"39","author":"Yao","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128776_bb0140","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3390\/toxins12050300","article-title":"Chronic Kidney Disease-associated immune dysfunctions: impact of protein-bound uremic retention solutes on immune cells","volume":"12","author":"Espi","year":"2020","journal-title":"Toxins"},{"key":"10.1016\/j.vaccine.2026.128776_bb0145","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1684\/ecn.2009.0153","article-title":"Antibody response to pneumococcal capsular polysaccharide vaccination in patients with chronic kidney disease","volume":"20","author":"Mahmoodi","year":"2009","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.vaccine.2026.128776_bb0150","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/ndt\/gfp397","article-title":"Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression","volume":"25","author":"Pahl","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.vaccine.2026.128776_bb0155","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000529971","article-title":"Enhancing immune protection in hemodialysis patients: role of the polymethyl methacrylate membrane","volume":"52","author":"Franzin","year":"2023","journal-title":"Blood Purif."},{"key":"10.1016\/j.vaccine.2026.128776_bb0160","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1523-1755.2003.00803.x","article-title":"Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients","volume":"63","author":"Kalantar-Zadeh","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.vaccine.2026.128776_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14186533","article-title":"The impact of hemodialysis on humoral and cellular immunity in patients with renal failure","volume":"14","author":"Alhamawi","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.vaccine.2026.128776_bb0170","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1681\/ASN.V131204","article-title":"Early T Cell activation correlates with expression of apoptosis markers in patients with end-stage renal disease","volume":"13","author":"Meier","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.vaccine.2026.128776_bb0175","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.humimm.2021.11.003","article-title":"T cell subpopulations and cytokine levels in hemodialysis patients","volume":"83","author":"Lisowska","year":"2022","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.vaccine.2026.128776_bb0180","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3858\/emm.2012.44.8.053","article-title":"B cell-associated immune profiles in patients with end-stage renal disease (ESRD)","volume":"44","author":"Kim","year":"2012","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.vaccine.2026.128776_bb0185","article-title":"Distribution characteristics of circulating B cell subpopulations in patients with chronic kidney disease","volume":"13","author":"Chen","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.vaccine.2026.128776_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102822","article-title":"Osteoimmunology and aging: mechanisms, implications, and therapeutic perspectives","volume":"111","author":"Wang","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.vaccine.2026.128776_bb0195","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1016\/S0021-9258(18)91045-8","article-title":"Parathyroid hormone receptors in circulating human mononuclear leukocytes","volume":"259","author":"Perry","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vaccine.2026.128776_bb0200","doi-asserted-by":"crossref","first-page":"315","DOI":"10.14740\/jocmr1999w","article-title":"Variability in response to Hepatitis B vaccine in hemodialysis patients","volume":"7","author":"El-Charabaty","year":"2015","journal-title":"J. Clin. Med. Res."},{"key":"10.1016\/j.vaccine.2026.128776_bb0205","doi-asserted-by":"crossref","first-page":"218","DOI":"10.4103\/1658-631X.213302","article-title":"Evaluation of response to hepatitis B vaccination in chronic hemodialysis patients","volume":"5","author":"Almueilo","year":"2017","journal-title":"Saudi J. Med. Med. Sci."},{"key":"10.1016\/j.vaccine.2026.128776_bb0210","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s40620-019-00668-1","article-title":"Hepatitis B virus vaccine immune response and mortality in dialysis patients: a meta-analysis","volume":"33","author":"Udomkarnjananun","year":"2019","journal-title":"J Nephrol"},{"key":"10.1016\/j.vaccine.2026.128776_bb0215","doi-asserted-by":"crossref","first-page":"289","DOI":"10.26900\/hsq.2750","article-title":"The effects of hemodialysis on oxidative stress in patients with chronic kidney failure","volume":"5","author":"Duysak","year":"2025","journal-title":"Health Sci. Q."},{"key":"10.1016\/j.vaccine.2026.128776_bb0220","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1440-1797.2012.01640.x","article-title":"Accumulation of circulating advanced oxidation protein products is an independent risk factor for ischaemic heart disease in maintenance haemodialysis patients","volume":"17","author":"Zhou","year":"2012","journal-title":"Nephrology"},{"key":"10.1016\/j.vaccine.2026.128776_bb0225","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0891-5849(91)90192-6","article-title":"Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes","volume":"11","author":"Esterbauer","year":"1991","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.vaccine.2026.128776_bb0230","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.numecd.2005.05.003","article-title":"A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress","volume":"15","author":"Del Rio","year":"2005","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.vaccine.2026.128776_bb0235","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ki.1996.186","article-title":"Advanced oxidation protein products as a novel marker of oxidative stress in uremia","volume":"49","author":"Witko-Sarsat","year":"1996","journal-title":"Kidney Int."},{"key":"10.1016\/j.vaccine.2026.128776_bb0240","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbadis.2004.02.008","article-title":"Biochemical and spectrophotometric significance of advanced oxidized protein products","volume":"1689","author":"Capeill\u00e8re-Blandin","year":"2004","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.vaccine.2026.128776_bb0245","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/sdi.12745","article-title":"Oxidative stress in hemodialysis: Causative mechanisms, clinical implications, and possible therapeutic interventions","volume":"32","author":"Liakopoulos","year":"2018","journal-title":"Semin. Dial."},{"key":"10.1016\/j.vaccine.2026.128776_bb0250","article-title":"Oxidative stress in antigen processing and presentation","volume":"4","author":"Chang","year":"2025","journal-title":"MedComm Oncol"},{"key":"10.1016\/j.vaccine.2026.128776_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110069","article-title":"ROS fine-tunes the function and fate of immune cells","volume":"119","author":"Liu","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.vaccine.2026.128776_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.652687","article-title":"Metabolic reprogramming and reactive oxygen species in T cell immunity","volume":"12","author":"Peng","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.vaccine.2026.128776_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1199233","article-title":"Reactive oxygen species formation and its effect on CD4+ T cell-mediated inflammation","volume":"14","author":"Shu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.vaccine.2026.128776_bb0270","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.molimm.2007.05.008","article-title":"Oxidative microenvironment exerts an opposite regulatory effect on cytokine production by Th1 and Th2 cells","volume":"45","author":"Frossi","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.vaccine.2026.128776_bb0275","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.freeradbiomed.2016.08.026","article-title":"Oxidative stress modulates the cytokine response of differentiated Th17 and Th1 cells","volume":"99","author":"Abimannan","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.vaccine.2026.128776_bb0280","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","article-title":"T cell subsets and their signature cytokines in autoimmune and inflammatory diseases","volume":"74","author":"Raphael","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.vaccine.2026.128776_bb0285","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1189\/jlb.2AB0116-045R","article-title":"AQP8 transports NOX2-generated H2O2 across the plasma membrane to promote signaling in B cells","volume":"100","author":"Bertolotti","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.vaccine.2026.128776_bb0290","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1365-2567.1996.431546.x","article-title":"Oxidative stress triggers tyrosine phosphorylation in B cells through a redox- and inflammatory cytokine-sensitive mechanism","volume":"87","author":"Suzuki","year":"1996","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2026.128776_bb0295","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-54871-7","article-title":"Dynamic hydrogen peroxide levels reveal a rate-dependent sensitivity in B-cell lymphoma signaling","volume":"14","author":"Witmond","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.vaccine.2026.128776_bb0300","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.immuni.2011.09.021","article-title":"The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation","volume":"35","author":"Wang","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2026.128776_bb0305","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/mrm.1910290307","article-title":"Metabolic changes in activated T cells: An NMR study of human peripheral blood lymphocytes","volume":"29","author":"Bental","year":"2005","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.vaccine.2026.128776_bb0310","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1021\/pr200328f","article-title":"Metabolomics of B to plasma cell differentiation","volume":"10","author":"Garcia-Manteiga","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.vaccine.2026.128776_bb0315","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.immuni.2004.06.010","article-title":"XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation","volume":"21","author":"Shaffer","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2026.128776_bb0320","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.immuni.2016.06.011","article-title":"Mitochondrial pyruvate import promotes long-term survival of antibody-secreting plasma cells","volume":"45","author":"Lam","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2026.128776_bb0325","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0026-0495(89)90136-4","article-title":"Metabolism of glutamine in lymphocytes","volume":"38","author":"Brand","year":"1989","journal-title":"Metabolism"},{"key":"10.1016\/j.vaccine.2026.128776_bb0330","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3892\/br.2017.980","article-title":"Comparison of the effect of the aerobic glycolysis inhibitor dichloroacetate and of the Krebs cycle inhibitor LW6 on cellular and humoral alloimmunity","volume":"7","author":"Eleftheriadis","year":"2017","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.vaccine.2026.128776_bb0335","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.vaccine.2026.128776_bb0340","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ebiom.2017.10.027","article-title":"Metabolomics and gene expression analysis reveal down-regulation of the citric acid (TCA) cycle in non-diabetic CKD patients","volume":"26","author":"Hallan","year":"2017","journal-title":"EBioMedicine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26005852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26005852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T14:52:13Z","timestamp":1781103133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26005852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":68,"alternative-id":["S0264410X26005852"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128776","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid peroxidation marker malondialdehyde is an independent determinant of hepatitis B vaccine response in hemodialysis patients","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128776","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128776"}}